• No products in the cart.


Requested resource is not accessible

To support the establishment of new cancer registries and maintain good quality cancer registries in Africa, by providing access to education, training, research and Mentorship.

Eldroret, Kenya

21st July 2020 – 29th September 2020

Course Director: Prof. Fredrick Chite Asirwa MD

Consultant Physician. Medical Oncologist & Hematologist

Executive Director/CEO: International Cancer Institute (ICI)

P.O. Box 8088, Code 30100 Eldoret, Kenya

Email: director@intercancer.com Website: www.intercancer.com

Lead Faculty: Gladys Chesumbai Onyango

IARC-GICR Regional Trainer.

CANREG 5 Consultant: African Cancer Registry Network.

Cancer Registry Coodinator: The Eldoret Cancer Registry.

P.O. Box 4606-30100, Eldoret, KENYA.


IARC-AFCRN Acrredited Faculty

This educational activity is provided by International Cancer Institute (ICI)

This activity is supported by educational grant from BMSF

Disclosure of Conflicts of Interest

Disclosure of Conflicts of Interest International Cancer Institute (ICI) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labelled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation and Request for Credit.

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.


Each topic takes 2 hours, Interactive Sessions done on Zoom, Course evaluation forms filled by each participant.

Participants should be willing to spend at least 4 hours per week on this online course over a period of 10 weeks. (Duration 40 hours)

All those interested in registration to this course, please send your information to education@intercancer.com



ICI acknowledges that the funding for this preceptorship training has been proudly supported by the Bristol-Myers Squibb Foundation (BMSF) Secure the Future Programme.





Course Reviews


  • 5 stars0
  • 4 stars0
  • 3 stars0
  • 2 stars0
  • 1 stars0

No Reviews found for this course.

© 2022 International Cancer Institute. All Rights Reserved